TherapeuticsMD Inc (TXMD)

4.00
0.21 4.99
AMEX : Health Care
Prev Close 4.21
Open 4.15
Day Low/High 3.97 / 4.24
52 Wk Low/High 5.18 / 11.26
Volume 2.07M
Avg Volume 3.49M
Exchange AMEX
Shares Outstanding 203.93M
Market Cap 858.53M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Complaint To Recover Losses Suffered By Investors In TherapeuticsMD, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Complaint To Recover Losses Suffered By Investors In TherapeuticsMD, Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of TherapeuticsMD, Inc.

TherapeuticsMD Announces Presentation At Bank Of America Merrill Lynch 2017 Healthcare Conference On May 16

TherapeuticsMD Announces Presentation At Bank Of America Merrill Lynch 2017 Healthcare Conference On May 16

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that the company's CEO Robert Finizio will present at the Bank of America Merrill Lynch 2017 Healthcare Conference in Las...

Analysts' Actions -- Costco, J.C. Penney, Cisco, TherapeuticsMD and More

Analysts' Actions -- Costco, J.C. Penney, Cisco, TherapeuticsMD and More

Here are Tuesday's top research calls, including downgrades for Cisco Systems and TherapeuticsMD, and new coverage of Costco and J.C. Penney.

Law Offices Of Howard G. Smith Reminds TherapeuticsMD, Inc. Investors Of Upcoming Lead Plaintiff Deadline And Encourages Investors To Contact The Firm

Law Offices Of Howard G. Smith Reminds TherapeuticsMD, Inc. Investors Of Upcoming Lead Plaintiff Deadline And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith reminds investors of the upcoming June 19, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased or otherwise acquired...

TXMD SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving TherapeuticsMD, Inc. And A Lead Plaintiff Deadline Of June 19, 2017

TXMD SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving TherapeuticsMD, Inc. And A Lead Plaintiff Deadline Of June 19, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased TherapeuticsMD, Inc.

Exiting Health Care Name

We'll close our TherapeuticsMD position with a likely major reset to expectations for the balance of 2017 and 2018.

TherapeuticsMD Rejected by FDA, Delay Could Be Fatal

TherapeuticsMD Rejected by FDA, Delay Could Be Fatal

The FDA wants 12-month endometrial safety data on TX-004HR. TherapeuticsMD conducted a single study that lasted just 12 weeks.

TherapeuticsMD Receives Complete Response Letter From FDA For TX-004HR New Drug Application

TherapeuticsMD Receives Complete Response Letter From FDA For TX-004HR New Drug Application

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that it received a Complete Response Letter (CRL) from the U.

Warily Awaiting TherapeuticsMD Call

The drug maker this morning is going to share the results of an FDA ruling, and we're concerned that the Street will shoot first and ask questions later.

TherapeuticsMD To Host TX-004HR Regulatory Update Conference Call And Webcast On May 8

TherapeuticsMD To Host TX-004HR Regulatory Update Conference Call And Webcast On May 8

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that, based upon the company's expectation that the U.

TherapeuticsMD Announces First Quarter 2017 Financial Results

TherapeuticsMD Announces First Quarter 2017 Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced its financial results for the quarter ended March 31, 2017.

Putting Up a Fight on TherapeuticsMD

Finding some protection against a possibly significant downside event.

Stocks Under $10 Weekly Summary

During a busy week of earnings and data, we exited 2 positions and initiated a small one.

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In TherapeuticsMD, Inc. To Contact The Firm

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In TherapeuticsMD, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in TherapeuticsMD, Inc.

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against TherapeuticsMD, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against TherapeuticsMD, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against TherapeuticsMD, Inc.

Stocks Under $10 Weekly Summary

We exited one position and downgraded another as earnings season heated up.

TherapeuticsMD Hormone Pill Faces Looming FDA Rejection and a Hostile Commercial Market

TherapeuticsMD Hormone Pill Faces Looming FDA Rejection and a Hostile Commercial Market

Postmenopausal women already have a broad menu of locally administered estrogen therapy products to treat vulvar and vaginal atrophy.

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against TherapeuticsMD, Inc.

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against TherapeuticsMD, Inc.

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against TherapeuticsMD, Inc.

Downgrading TherapeuticsMD

Company commentary this morning adds layer of uncertainty, which warrants being extra cautious.

TherapeuticsMD Provides Additional Information On TX-004HR Regulatory Update

TherapeuticsMD Provides Additional Information On TX-004HR Regulatory Update

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that, based on continued correspondence with the U.

Exiting a Financial Position

We are selling our holdings in Synovus Financial on today's strength. Plus, an update on TherapeuticsMD.